Oluwaseun Johnson-Akeju, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Delirium | 22 | 2023 | 1609 | 3.840 |
Why?
|
Dexmedetomidine | 11 | 2023 | 315 | 2.380 |
Why?
|
Ketamine | 11 | 2023 | 500 | 2.280 |
Why?
|
Electroencephalography | 31 | 2023 | 6150 | 2.070 |
Why?
|
Propofol | 9 | 2023 | 628 | 1.680 |
Why?
|
Hypnotics and Sedatives | 13 | 2021 | 1161 | 1.600 |
Why?
|
Anesthetics, Inhalation | 7 | 2020 | 570 | 1.520 |
Why?
|
Anesthesia, General | 11 | 2020 | 1165 | 1.510 |
Why?
|
Cardiac Surgical Procedures | 8 | 2023 | 3533 | 1.030 |
Why?
|
Neuroglia | 6 | 2019 | 927 | 0.930 |
Why?
|
Anesthetics, Intravenous | 4 | 2017 | 417 | 0.840 |
Why?
|
Brain | 22 | 2023 | 26413 | 0.800 |
Why?
|
Brain Waves | 4 | 2021 | 401 | 0.770 |
Why?
|
Methyl Ethers | 4 | 2019 | 205 | 0.760 |
Why?
|
Anesthetics, Dissociative | 2 | 2021 | 80 | 0.750 |
Why?
|
Intensive Care Units | 11 | 2023 | 3680 | 0.720 |
Why?
|
Consciousness | 4 | 2019 | 572 | 0.710 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 3 | 2018 | 87 | 0.660 |
Why?
|
Respiratory Insufficiency | 3 | 2023 | 1199 | 0.660 |
Why?
|
Sleep | 13 | 2023 | 4623 | 0.660 |
Why?
|
Arousal | 4 | 2018 | 1165 | 0.650 |
Why?
|
Receptors, GABA | 8 | 2023 | 288 | 0.620 |
Why?
|
Sleep Stages | 4 | 2020 | 686 | 0.620 |
Why?
|
Cardiopulmonary Bypass | 4 | 2021 | 1066 | 0.610 |
Why?
|
Migraine with Aura | 2 | 2020 | 203 | 0.600 |
Why?
|
Fentanyl | 2 | 2020 | 410 | 0.570 |
Why?
|
Anesthesia | 6 | 2020 | 1548 | 0.550 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2021 | 449 | 0.530 |
Why?
|
Nitric Oxide | 3 | 2024 | 2131 | 0.530 |
Why?
|
Malnutrition | 2 | 2022 | 625 | 0.500 |
Why?
|
Sleep Apnea Syndromes | 2 | 2022 | 943 | 0.460 |
Why?
|
Isoflurane | 2 | 2017 | 380 | 0.460 |
Why?
|
Electrocardiography | 5 | 2021 | 6442 | 0.450 |
Why?
|
Low Back Pain | 2 | 2022 | 956 | 0.440 |
Why?
|
Heart Rate | 5 | 2021 | 4092 | 0.440 |
Why?
|
Endocannabinoids | 1 | 2023 | 116 | 0.430 |
Why?
|
Unconsciousness | 4 | 2020 | 263 | 0.410 |
Why?
|
Humans | 104 | 2024 | 744220 | 0.410 |
Why?
|
Positron-Emission Tomography | 11 | 2023 | 6274 | 0.380 |
Why?
|
Monitoring, Intraoperative | 2 | 2018 | 953 | 0.360 |
Why?
|
Macaca | 1 | 2021 | 440 | 0.360 |
Why?
|
Sulfonic Acids | 1 | 2020 | 96 | 0.360 |
Why?
|
Confusion | 1 | 2022 | 275 | 0.350 |
Why?
|
Persian Gulf Syndrome | 1 | 2020 | 45 | 0.350 |
Why?
|
Antidepressive Agents | 4 | 2023 | 2839 | 0.350 |
Why?
|
Rest | 2 | 2023 | 901 | 0.350 |
Why?
|
Dementia | 3 | 2023 | 2518 | 0.350 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2020 | 117 | 0.340 |
Why?
|
Preoptic Area | 1 | 2020 | 146 | 0.340 |
Why?
|
Periodicity | 1 | 2020 | 363 | 0.340 |
Why?
|
Meninges | 1 | 2020 | 190 | 0.320 |
Why?
|
Anesthetics | 3 | 2018 | 538 | 0.320 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2022 | 271 | 0.320 |
Why?
|
Adult | 44 | 2023 | 214035 | 0.320 |
Why?
|
Suicidal Ideation | 2 | 2018 | 1248 | 0.320 |
Why?
|
Carbamazepine | 1 | 2019 | 229 | 0.320 |
Why?
|
Anesthetics, General | 2 | 2017 | 152 | 0.310 |
Why?
|
Anesthesia Recovery Period | 1 | 2018 | 157 | 0.300 |
Why?
|
Respiration | 2 | 2021 | 1651 | 0.300 |
Why?
|
Respiration, Artificial | 5 | 2023 | 2569 | 0.300 |
Why?
|
Acetamides | 2 | 2018 | 249 | 0.290 |
Why?
|
Analgesics | 2 | 2021 | 1040 | 0.290 |
Why?
|
Male | 51 | 2023 | 350027 | 0.280 |
Why?
|
Deep Sedation | 1 | 2018 | 121 | 0.280 |
Why?
|
Aged | 32 | 2023 | 163253 | 0.280 |
Why?
|
Pyridines | 4 | 2018 | 2822 | 0.280 |
Why?
|
Dopamine | 1 | 2023 | 1591 | 0.280 |
Why?
|
Locus Coeruleus | 1 | 2017 | 176 | 0.280 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2016 | 62 | 0.270 |
Why?
|
Critical Care | 3 | 2020 | 2644 | 0.270 |
Why?
|
Administration, Inhalation | 3 | 2024 | 1104 | 0.270 |
Why?
|
Nutritional Status | 2 | 2022 | 1609 | 0.270 |
Why?
|
Nerve Net | 3 | 2018 | 2175 | 0.270 |
Why?
|
Research Personnel | 1 | 2021 | 573 | 0.270 |
Why?
|
Education, Distance | 1 | 2019 | 251 | 0.270 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2020 | 454 | 0.270 |
Why?
|
Forearm | 1 | 2018 | 409 | 0.260 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 712 | 0.260 |
Why?
|
Encephalitis | 1 | 2019 | 423 | 0.260 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2016 | 1423 | 0.250 |
Why?
|
Critical Illness | 4 | 2021 | 2670 | 0.250 |
Why?
|
Delta Rhythm | 1 | 2015 | 78 | 0.250 |
Why?
|
Female | 48 | 2023 | 380197 | 0.250 |
Why?
|
Polysomnography | 4 | 2022 | 1775 | 0.250 |
Why?
|
Middle Aged | 34 | 2023 | 213367 | 0.250 |
Why?
|
Neuronal Plasticity | 2 | 2017 | 1422 | 0.250 |
Why?
|
Nitrous Oxide | 1 | 2015 | 177 | 0.240 |
Why?
|
Anesthesia, Inhalation | 1 | 2015 | 223 | 0.240 |
Why?
|
Motor Neurons | 2 | 2016 | 855 | 0.240 |
Why?
|
Autonomic Nervous System | 1 | 2019 | 671 | 0.240 |
Why?
|
Brain Diseases | 2 | 2022 | 1564 | 0.240 |
Why?
|
Fibromyalgia | 1 | 2018 | 388 | 0.240 |
Why?
|
Embryoid Bodies | 1 | 2014 | 67 | 0.230 |
Why?
|
Synaptic Transmission | 1 | 2019 | 1179 | 0.230 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 3674 | 0.220 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1004 | 0.220 |
Why?
|
Cerebral Cortex | 3 | 2023 | 5709 | 0.220 |
Why?
|
Frail Elderly | 3 | 2023 | 693 | 0.220 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 3239 | 0.220 |
Why?
|
Orthopedics | 1 | 2022 | 904 | 0.220 |
Why?
|
Anti-Retroviral Agents | 1 | 2022 | 1715 | 0.210 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.210 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2022 | 1812 | 0.200 |
Why?
|
Postoperative Complications | 7 | 2023 | 15294 | 0.200 |
Why?
|
Alzheimer Disease | 2 | 2023 | 8037 | 0.200 |
Why?
|
Receptors, GABA-A | 1 | 2016 | 627 | 0.200 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 1356 | 0.190 |
Why?
|
Orthopedic Procedures | 1 | 2021 | 1288 | 0.190 |
Why?
|
Osteoarthritis, Knee | 1 | 2021 | 1222 | 0.190 |
Why?
|
Pain Measurement | 1 | 2020 | 3419 | 0.190 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2018 | 1018 | 0.190 |
Why?
|
Neural Pathways | 3 | 2017 | 2972 | 0.180 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2018 | 1537 | 0.180 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1458 | 0.180 |
Why?
|
Pandemics | 4 | 2023 | 8387 | 0.180 |
Why?
|
Depressive Disorder, Major | 2 | 2018 | 4645 | 0.170 |
Why?
|
Young Adult | 14 | 2021 | 56436 | 0.170 |
Why?
|
Retrospective Studies | 14 | 2023 | 77426 | 0.170 |
Why?
|
Geriatric Assessment | 3 | 2022 | 1372 | 0.170 |
Why?
|
Hypothermia, Induced | 1 | 2015 | 752 | 0.170 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2022 | 8950 | 0.170 |
Why?
|
Embryonic Development | 1 | 2014 | 711 | 0.170 |
Why?
|
Motor Cortex | 1 | 2016 | 986 | 0.170 |
Why?
|
Anticonvulsants | 1 | 2019 | 1917 | 0.170 |
Why?
|
Patient Care Team | 1 | 2020 | 2529 | 0.170 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2021 | 10949 | 0.160 |
Why?
|
Prospective Studies | 10 | 2023 | 53280 | 0.160 |
Why?
|
Thalamus | 1 | 2014 | 1024 | 0.160 |
Why?
|
Wounds and Injuries | 1 | 2021 | 2400 | 0.160 |
Why?
|
Ventricular Fibrillation | 1 | 2011 | 538 | 0.160 |
Why?
|
Hospitalization | 3 | 2023 | 10262 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 10 | 2022 | 35423 | 0.150 |
Why?
|
Guideline Adherence | 1 | 2018 | 2266 | 0.150 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2003 | 0.150 |
Why?
|
Circadian Rhythm | 2 | 2023 | 2624 | 0.150 |
Why?
|
Aging | 4 | 2023 | 8661 | 0.150 |
Why?
|
Veterans | 1 | 2020 | 2519 | 0.140 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5755 | 0.140 |
Why?
|
Administration, Oral | 3 | 2020 | 3913 | 0.140 |
Why?
|
Neurons | 3 | 2020 | 9335 | 0.130 |
Why?
|
Developmental Disabilities | 1 | 2014 | 1456 | 0.130 |
Why?
|
Carbon Radioisotopes | 2 | 2018 | 592 | 0.130 |
Why?
|
Time Factors | 7 | 2023 | 40063 | 0.130 |
Why?
|
Exercise | 1 | 2021 | 5615 | 0.130 |
Why?
|
Age Factors | 4 | 2020 | 18367 | 0.130 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2662 | 0.120 |
Why?
|
Hypertension | 2 | 2022 | 8480 | 0.120 |
Why?
|
Brain Mapping | 2 | 2017 | 6671 | 0.120 |
Why?
|
Neurotoxicity Syndromes | 1 | 2017 | 290 | 0.110 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 25043 | 0.110 |
Why?
|
Institutionalization | 1 | 2023 | 104 | 0.110 |
Why?
|
Thalamic Nuclei | 1 | 2023 | 114 | 0.110 |
Why?
|
Mitochondria, Heart | 1 | 2004 | 247 | 0.110 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2023 | 143 | 0.110 |
Why?
|
N-Methylaspartate | 1 | 2023 | 231 | 0.110 |
Why?
|
Physicians | 1 | 2021 | 4564 | 0.110 |
Why?
|
Stroke | 2 | 2020 | 9981 | 0.110 |
Why?
|
Nucleic Acid Conformation | 1 | 2006 | 914 | 0.110 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3132 | 0.100 |
Why?
|
Neurophysiology | 1 | 2023 | 142 | 0.100 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1620 | 0.100 |
Why?
|
Adolescent | 10 | 2020 | 85759 | 0.100 |
Why?
|
Brain Injuries | 1 | 2013 | 2025 | 0.100 |
Why?
|
Astrocytes | 2 | 2020 | 1270 | 0.100 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 2408 | 0.100 |
Why?
|
Infusions, Intravenous | 2 | 2017 | 2272 | 0.100 |
Why?
|
Pilot Projects | 3 | 2020 | 8321 | 0.100 |
Why?
|
Double-Blind Method | 3 | 2020 | 12035 | 0.100 |
Why?
|
Risk Factors | 6 | 2023 | 72280 | 0.090 |
Why?
|
Glycolysis | 1 | 2004 | 826 | 0.090 |
Why?
|
Pyridostigmine Bromide | 1 | 2020 | 31 | 0.090 |
Why?
|
Gulf War | 1 | 2020 | 29 | 0.090 |
Why?
|
Respiratory Rate | 1 | 2021 | 162 | 0.090 |
Why?
|
Inflammation | 1 | 2020 | 10634 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2023 | 1590 | 0.090 |
Why?
|
Choline | 1 | 2021 | 493 | 0.090 |
Why?
|
Algorithms | 3 | 2021 | 13885 | 0.090 |
Why?
|
Hyperalgesia | 1 | 2023 | 502 | 0.090 |
Why?
|
Creatine | 1 | 2021 | 421 | 0.090 |
Why?
|
Actigraphy | 1 | 2023 | 488 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4929 | 0.080 |
Why?
|
Incidence | 3 | 2023 | 20945 | 0.080 |
Why?
|
Aspartic Acid | 1 | 2021 | 576 | 0.080 |
Why?
|
Neoplastic Stem Cells | 1 | 2007 | 1376 | 0.080 |
Why?
|
Drug Synergism | 2 | 2017 | 1791 | 0.080 |
Why?
|
Organizational Objectives | 1 | 2020 | 438 | 0.080 |
Why?
|
Length of Stay | 2 | 2022 | 6308 | 0.080 |
Why?
|
Occipital Lobe | 1 | 2020 | 380 | 0.080 |
Why?
|
Markov Chains | 1 | 2021 | 969 | 0.080 |
Why?
|
Coma | 1 | 2021 | 475 | 0.080 |
Why?
|
Half-Life | 1 | 2019 | 659 | 0.080 |
Why?
|
Nutrition Assessment | 1 | 2021 | 723 | 0.080 |
Why?
|
Nitrosourea Compounds | 1 | 2007 | 32 | 0.080 |
Why?
|
Sequence Analysis, RNA | 1 | 2006 | 2013 | 0.080 |
Why?
|
Electrophysiological Phenomena | 1 | 2019 | 315 | 0.080 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2023 | 895 | 0.080 |
Why?
|
Animals | 9 | 2023 | 168788 | 0.080 |
Why?
|
Hospitals | 2 | 2022 | 3952 | 0.080 |
Why?
|
Beta Rhythm | 1 | 2017 | 58 | 0.080 |
Why?
|
Anesthesiology | 1 | 2017 | 1049 | 0.070 |
Why?
|
Stathmin | 1 | 2007 | 71 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2018 | 6037 | 0.070 |
Why?
|
Models, Animal | 1 | 2023 | 2171 | 0.070 |
Why?
|
Neuroimmunomodulation | 1 | 2018 | 157 | 0.070 |
Why?
|
Comorbidity | 2 | 2022 | 10387 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2006 | 3505 | 0.070 |
Why?
|
Sensation | 1 | 2018 | 337 | 0.070 |
Why?
|
Cortical Spreading Depression | 1 | 2020 | 276 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2022 | 3158 | 0.070 |
Why?
|
Patients | 1 | 2023 | 900 | 0.070 |
Why?
|
Inhibitory Postsynaptic Potentials | 1 | 2016 | 67 | 0.070 |
Why?
|
Theta Rhythm | 1 | 2017 | 207 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2022 | 21752 | 0.070 |
Why?
|
Probability | 1 | 2021 | 2505 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2007 | 3023 | 0.070 |
Why?
|
Efficiency, Organizational | 1 | 2020 | 695 | 0.070 |
Why?
|
Skull | 1 | 2020 | 813 | 0.070 |
Why?
|
HIV Infections | 1 | 2022 | 16718 | 0.070 |
Why?
|
Oligodendroglioma | 1 | 2007 | 279 | 0.070 |
Why?
|
Cross-Over Studies | 1 | 2020 | 2032 | 0.060 |
Why?
|
Prevalence | 2 | 2022 | 15226 | 0.060 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 977 | 0.060 |
Why?
|
Communicable Disease Control | 1 | 2022 | 857 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15161 | 0.060 |
Why?
|
Morbidity | 1 | 2020 | 1769 | 0.060 |
Why?
|
Nursing Homes | 1 | 2022 | 1036 | 0.060 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2007 | 658 | 0.060 |
Why?
|
Indoles | 1 | 2023 | 1838 | 0.060 |
Why?
|
Area Under Curve | 1 | 2019 | 1655 | 0.060 |
Why?
|
Tissue Distribution | 1 | 2019 | 2335 | 0.060 |
Why?
|
Safety Management | 1 | 2020 | 782 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3311 | 0.060 |
Why?
|
Hypothalamus | 1 | 2020 | 1063 | 0.060 |
Why?
|
Needs Assessment | 1 | 2020 | 1147 | 0.060 |
Why?
|
Alpha Rhythm | 1 | 2014 | 120 | 0.060 |
Why?
|
Drug Interactions | 1 | 2019 | 1458 | 0.060 |
Why?
|
Dizocilpine Maleate | 1 | 2014 | 176 | 0.060 |
Why?
|
Program Development | 1 | 2020 | 1315 | 0.060 |
Why?
|
Prognosis | 3 | 2022 | 29050 | 0.060 |
Why?
|
Reference Standards | 1 | 2017 | 1025 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2022 | 57768 | 0.060 |
Why?
|
Thrombectomy | 1 | 2018 | 679 | 0.060 |
Why?
|
Hypothermia | 1 | 2015 | 189 | 0.060 |
Why?
|
Sex Characteristics | 1 | 2023 | 2586 | 0.060 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 611 | 0.050 |
Why?
|
Cohort Studies | 3 | 2021 | 40559 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 6765 | 0.050 |
Why?
|
Evoked Potentials | 1 | 2018 | 1057 | 0.050 |
Why?
|
Survival Rate | 2 | 2021 | 12781 | 0.050 |
Why?
|
tau Proteins | 1 | 2022 | 1868 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5853 | 0.050 |
Why?
|
Proteomics | 2 | 2021 | 3637 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5034 | 0.050 |
Why?
|
Glioblastoma | 1 | 2007 | 3481 | 0.050 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1195 | 0.050 |
Why?
|
Myoblasts, Cardiac | 1 | 2011 | 23 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2204 | 0.050 |
Why?
|
Myocardium | 1 | 2004 | 4776 | 0.050 |
Why?
|
Brain Neoplasms | 2 | 2007 | 8860 | 0.050 |
Why?
|
Behavior | 1 | 2014 | 560 | 0.050 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 365 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2759 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1623 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2023 | 499 | 0.050 |
Why?
|
Microarray Analysis | 1 | 2014 | 766 | 0.050 |
Why?
|
Noise | 1 | 2023 | 279 | 0.050 |
Why?
|
Perioperative Care | 1 | 2018 | 1000 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3760 | 0.050 |
Why?
|
Outpatients | 1 | 2018 | 1486 | 0.050 |
Why?
|
Remission Induction | 1 | 2016 | 2389 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2018 | 1737 | 0.050 |
Why?
|
Hemodynamics | 1 | 2020 | 4199 | 0.050 |
Why?
|
Pyrimidines | 2 | 2017 | 2940 | 0.050 |
Why?
|
Cause of Death | 1 | 2021 | 3584 | 0.050 |
Why?
|
Microglia | 1 | 2018 | 1266 | 0.050 |
Why?
|
Occupational Exposure | 1 | 2020 | 1796 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2011 | 11728 | 0.040 |
Why?
|
Rats | 2 | 2020 | 24273 | 0.040 |
Why?
|
Oxygen | 1 | 2021 | 4187 | 0.040 |
Why?
|
Mortality | 1 | 2021 | 2864 | 0.040 |
Why?
|
Mice | 3 | 2023 | 81178 | 0.040 |
Why?
|
Kinetics | 1 | 2017 | 6474 | 0.040 |
Why?
|
Seizures | 1 | 2022 | 2859 | 0.040 |
Why?
|
Patient Discharge | 1 | 2022 | 3313 | 0.040 |
Why?
|
Life Style | 1 | 2021 | 3835 | 0.040 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2015 | 1123 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 1 | 2020 | 8302 | 0.040 |
Why?
|
Electrophysiology | 1 | 2011 | 1310 | 0.040 |
Why?
|
Embryo, Mammalian | 1 | 2014 | 1701 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2022 | 5316 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1183 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2015 | 2715 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39045 | 0.040 |
Why?
|
Okadaic Acid | 1 | 2007 | 67 | 0.040 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.040 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 1 | 2007 | 28 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18027 | 0.040 |
Why?
|
Databases, Factual | 1 | 2022 | 7730 | 0.040 |
Why?
|
Psychometrics | 1 | 2016 | 3002 | 0.040 |
Why?
|
Diffusion Tensor Imaging | 1 | 2016 | 2305 | 0.030 |
Why?
|
Odds Ratio | 1 | 2018 | 9849 | 0.030 |
Why?
|
Clinical Competence | 1 | 2020 | 4687 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2014 | 2715 | 0.030 |
Why?
|
Infant | 2 | 2017 | 35129 | 0.030 |
Why?
|
Boston | 1 | 2017 | 9311 | 0.030 |
Why?
|
Pluripotent Stem Cells | 1 | 2011 | 795 | 0.030 |
Why?
|
Tretinoin | 1 | 2007 | 517 | 0.030 |
Why?
|
Electron Transport | 1 | 2004 | 211 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15538 | 0.030 |
Why?
|
Child, Preschool | 2 | 2017 | 40992 | 0.030 |
Why?
|
Wakefulness | 1 | 2020 | 1245 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2011 | 1224 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2014 | 11478 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2014 | 5974 | 0.030 |
Why?
|
Pain | 1 | 2018 | 4987 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15070 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2004 | 910 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2004 | 480 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2007 | 5169 | 0.030 |
Why?
|
Glioma | 1 | 2007 | 3401 | 0.030 |
Why?
|
Warfarin | 1 | 2020 | 1496 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 9960 | 0.030 |
Why?
|
Protein Transport | 1 | 2007 | 1989 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4465 | 0.020 |
Why?
|
Base Sequence | 2 | 2007 | 12801 | 0.020 |
Why?
|
Attention | 1 | 2020 | 2399 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2007 | 6313 | 0.020 |
Why?
|
Child | 2 | 2017 | 77679 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2374 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2017 | 63119 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 279 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2603 | 0.020 |
Why?
|
Phosphorylation | 1 | 2007 | 8437 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9147 | 0.020 |
Why?
|
Anticoagulants | 1 | 2020 | 4599 | 0.020 |
Why?
|
Epilepsy | 1 | 2020 | 3310 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2015 | 3201 | 0.020 |
Why?
|
Proteome | 1 | 2004 | 1798 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2007 | 769 | 0.010 |
Why?
|
DNA Primers | 1 | 2007 | 2892 | 0.010 |
Why?
|
Pregnancy | 1 | 2014 | 29142 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2007 | 1758 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2007 | 10480 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2007 | 2649 | 0.010 |
Why?
|
Sex Factors | 1 | 2004 | 10396 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 12956 | 0.010 |
Why?
|
Risk Assessment | 1 | 2011 | 23337 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2007 | 4742 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15525 | 0.010 |
Why?
|
United States | 1 | 2023 | 69867 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 18116 | 0.010 |
Why?
|
Signal Transduction | 1 | 2007 | 23404 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 16687 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13668 | 0.000 |
Why?
|